ADVERTISEMENT
Lupin Falls After US FDA Inspects Goa Facility With Seven Observations
20 Sep 2021, 10:24 AM IST 
Lupin shares fell as much as 4 per cent to hit an intraday low of Rs 913.
Shares of the Mumbai-based drug maker - Lupin - fell as much as 4 per cent to hit an intraday low of Rs 913 after the company informed exchanges that the US drug regulator - US Food and Drug Administration (US FDA) concluded inspection of its Goa facility with seven observations.
